STERIS is a global provider of infection prevention products and services serving healthcare, medical device, and pharmaceutical customers. The company operates through three reportable segments: Healthcare, which supplies sterile processing consumables, capital equipment (sterilizers, automated endoscope reprocessors, surgical tables), and instrument repair services; Applied Sterilization Technologies (AST), which provides contract microbial reduction of medical devices; and Life Sciences. The company divested its Dental segment in fiscal 2025, which is presented as discontinued operations.
STERIS serves procedural areas including operating rooms, ambulatory surgery centers, and endoscopy suites, offering a mix of consumables, capital equipment, outsourced reprocessing, and OR connectivity solutions. Demand drivers cited include an aging global population entering peak healthcare consumption years, growth in preventive screening procedures such as endoscopies and colonoscopies, and customer preference for greater operational efficiency. The company positions its integrated product and service offering as a comprehensive solution for sterile processing departments.
Healthcare 71% · Applied Sterilization Technologies 19% · Life Science Member 10%
business segments · FY2026 (ended Mar 2026) · share of tagged segment revenue (10-K XBRL, as filed)
